The global liquid biopsy test sector is witnessing considerable growth, driven by progress in cancer detection and personalized healthcare. Current estimates position the market size at around USD X billion in 2024, with predictions suggesting a a estimated CAGR of Y.Z percent through 2032. Dominant trends encompass the increasing implementation of